Lynkeus Biotech GmbH
Records under this name other than patents Lynkeus Biotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Lynkeus Biotech GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,202,845 | Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification Formerly held Term ended Ended no later than Apr 16, 2023 · Medium confidence | Term ended | Ended no later than Apr 16, 2023 | Medium confidence |
| US 8,946,180 | Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification Formerly held Lapsed on the fee record Ended Feb 3, 2023 · High confidence | Lapsed on the fee record | Ended Feb 3, 2023 | High confidence |
| US 6,410,314 | Episomally replicating vector, its preparation and use Formerly held Lapsed on the fee record Ended Jun 25, 2010 · USPTO record | Lapsed on the fee record | Ended Jun 25, 2010 | USPTO record |